Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research

N Ahmed, KL Stenvers - Frontiers in oncology, 2013 - frontiersin.org
More than one third of ovarian cancer patients present with ascites at diagnosis, and almost
all have ascites at recurrence. The presence of ascites correlates with the peritoneal spread …

Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response

BP Rickard, C Conrad, AJ Sorrin, MK Ruhi, JC Reader… - Cancers, 2021 - mdpi.com
Simple Summary Accumulation of excess fluid in the abdomen typically indicates abnormal
function or disease, such as cancer, in the underlying tissues. This accumulation of fluid, or …

Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis

BE Lippitz, RA Harris - Oncoimmunology, 2016 - Taylor & Francis
Objective: In tumor patients, IL-6 appears to be one component of a consistent cancer-
associated cytokine network resulting in both a systemic immune stimulation and a …

Assessment and management of cancer-related fatigue in adults

K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The lancet, 2003 - thelancet.com
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …

The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer

SS Savant, S Sriramkumar, HM O'Hagan - Cancers, 2018 - mdpi.com
Inflammation plays a role in the initiation and development of many types of cancers,
including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a …

Mechanisms of transcoelomic metastasis in ovarian cancer

DSP Tan, R Agarwal, SB Kaye - The lancet oncology, 2006 - thelancet.com
Metastasis from epithelial ovarian cancer can occur via the transcoelomic,
haematogeneous, or lymphatic route. Of these, transcoelomic metastasis is the most …

Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer

R Salgado, S Junius, I Benoy… - … journal of cancer, 2003 - Wiley Online Library
Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells,
B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by …

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence

M Trikha, R Corringham, B Klein, JF Rossi - Clinical cancer research, 2003 - AACR
Abstract Interleukin (IL)-6, a pleiotropic cytokine with varied systemic functions, plays a major
role in inflammatory processes. It modulates the transcription of several liver-specific genes …

Development of a multimarker assay for early detection of ovarian cancer

Z Yurkovetsky, S Skates, A Lomakin, B Nolen… - Journal of Clinical …, 2010 - ascopubs.org
Purpose Early detection of ovarian cancer has great promise to improve clinical outcome.
Patients and Methods Ninety-six serum biomarkers were analyzed in sera from healthy …

Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine

MB Nilsson, RR Langley, IJ Fidler - Cancer research, 2005 - AACR
Angiogenesis, a key rate-limiting step in the growth and dissemination of malignant tumors,
is regulated by the balance between positive and negative effectors. Recent studies indicate …